Add Company
Join Now

Versado Training Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Training

Industry

Estimated Revenue & Valuation

  • Versado Training's estimated annual revenue is currently $2.8M per year.(i)
  • Versado Training's estimated revenue per employee is $102,667

Employee Data

  • Versado Training has 27 Employees.(i)
  • Versado Training grew their employee count by 23% last year.

Versado Training's People

NameTitleEmail/Phone
1
Founder, PresidentReveal Email/Phone
2
VP, Creative ServicesReveal Email/Phone
3
VP Sales and FinanceReveal Email/Phone
4
Editorial DirectorReveal Email/Phone
5
Director Talent DevelopmentReveal Email/Phone
6
Creative DirectorReveal Email/Phone
7
Director Learning ProductionReveal Email/Phone
8
Learner Experience SpecialistReveal Email/Phone
9
Junior Medical WriterReveal Email/Phone
10
Executive Learning ProducerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.5M40-11%N/AN/A
#2
$15.2M850%N/AN/A
#3
$15.3M9341%N/AN/A
#4
$3M240%N/AN/A
#5
$3.3M284%N/AN/A
#6
$672.9M28997%N/AN/A
#7
$18.5M11612%N/AN/A
#8
$2.8M2723%N/AN/A
#9
$27.4M137-2%N/AN/A
#10
$4.1M3111%N/AN/A
Add Company

What Is Versado Training?

Versado Training is a customized training solutions company specializing in sales-force development and medical education in the life sciences industry. Versado Training was honored by Inc. Magazine in their 2017 Annual List of America’s Fastest-Growing Private Companies. Partner organizations include Kindle Communications, Medical Leverage, and Snyder Inc. Clients include: Amgen, Astellas, Biogen, GlaxoSmithKline, Sucampo, Shire, Grifols, LivaNova, UCB Pharma, Spirit Aerospace, North Carolina State University, and University of Kentucky, among others.

keywords:N/A

N/A

Total Funding

27

Number of Employees

$2.8M

Revenue (est)

23%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A2735%N/A
#2
$3M274%N/A
#3
$5.1M278%N/A
#4
$2.8M270%N/A
#5
$5.6M27-21%$75M